What the Midterm Election Results Mean for 340B

The recent election results have implications for the future of U.S. health policy and the 340B program. Health policy experts Debbie Curtis and Rodney Whitlock join us this week to discuss how the new Congress will affect 340B and how individuals can best engage in educating and advocating for the program. Debbie and Rodney are vice presidents at McDermott + Consulting and previously were congressional staffers. Before the interview, we provide an update on the litigation process in the 340B contract pharmacy dispute, and we recap HRSA audit results of drug companies. What Divided Government Means for Health Policy Rodney and Debbie recap the election results, including some of the 340B congressional champions who are returning to Congress. They explain how a divided government will affect health policy issues that 340B hospitals care about, such as the COVID-19 public health emergency and disproportionate share hospital payments. 340B’s Spot on the New Congress’s Agenda Leadership changes in U.S. House and Senate committees that focus on health policy could affect whether lawmakers prioritize 340B issues in the new Congress. Our guests also discuss the importance of monitoring health policies the Biden administration is implementing that could affect 340B, such as the Inflation Reduction Act. Prepare to Educate Members of Congress about 340B As the year ends, hospitals and health systems need to prepare to engage with new and returning members of Congress. Rodney, Debbie, and interviewer Tom O’Donnell, 340B Health’s senior vice president of government relations, discuss the keys to educating members of Congress about the value of 340B.  Check out all of our episodes on the 340B Insight podcast website. You also can stay updated on all 340B Health news and information by visiting our homepage. If you have any questions you’d like us to cover in this podcast, email us at [email protected] Judges Mulling Decisions in Cases on Drug Company 340B Restrictions HRSA FY 2022 Manufacturer Audit Results340B Health Impact Profile Guide